Zoetis releases results of new Suvaxyn® PRRS MLV studies
Following its launch in January, Zoetis has released the results of a series of studies around the biological properties of Suvaxyn® PRRS MLV, an innovative vaccine containing a modified live European Porcine Reproductive and Respiratory Syndrome (PRRS) virus strain.
10 May 2018
2 minute read
